FilingIndex
← The Wire
ZVRANasdaq

ZEVRA THERAPEUTICS, INC.

Pharmaceutical Preparations · DE · CIK 1434647

Zevra Therapeutics develops and commercializes life-changing therapies for rare diseases

$748M
Market cap
$14.01
Last close
+3.6%
1D
+10.8%
5D
1.5M
Volume
Price · last 39 sessions+39.4%
May 4L $10.03 · H $14.01Jun 29
343
Total filings
Jun 5, 2026
Last filing
12/31
Fiscal year end
8-KShareholder VoteJun 5, 202610-Q10-QMay 6, 20268-KResults of OperationsMay 6, 2026DEF 14ADEF 14AApr 20, 20268-KMaterial Agreement · Agreement TerminatedMar 16, 202610-K10-KMar 9, 20268-KExecutive Change · Results of OperationsMar 9, 20268-KExecutive ChangeDec 17, 20258-KExecutive Change · Reg FD DisclosureDec 2, 20258-KExecutive Change · Reg FD DisclosureNov 20, 202510-Q10-QNov 5, 20258-KResults of OperationsNov 5, 202510-Q10-QAug 12, 20258-KResults of OperationsAug 12, 20258-KShareholder VoteMay 29, 2025DEFA14ADEFA14AMay 21, 202510-QFORM 10-QMay 13, 20258-KResults of OperationsMay 13, 2025DEFA14ADEFA14AMay 8, 2025DEFA14ADEFA14AApr 21, 2025DEFA14ADEFA14AApr 21, 2025DEFA14ADEFA14AApr 7, 20258-KAcquisition / Disposition · Results of OperationsApr 7, 2025DEFA14ADEFA14AMar 31, 2025DEFA14ADEFA14AMar 31, 202510-KFORM 10-KMar 12, 20258-KResults of OperationsMar 11, 20258-KMaterial Agreement · Reg FD DisclosureFeb 27, 20258-KExecutive Change · Reg FD DisclosureDec 6, 20248-KReg FD Disclosure · Company UpdateNov 22, 2024SC 13GZEVRA THERAPEUTICS, INC.Nov 14, 202410-QFORM 10-QNov 13, 20248-KResults of OperationsNov 12, 20248-KReg FD Disclosure · Company UpdateSep 20, 202410-QFORM 10-QAug 14, 20248-KResults of OperationsAug 13, 20248-KCompany UpdateAug 9, 2024424B5424B5Aug 9, 20248-KResults of OperationsAug 8, 2024424B5424B5Aug 8, 20248-KReg FD Disclosure · Company UpdateAug 5, 20248-KMaterial Agreement · Agreement TerminatedJul 12, 20248-KReg FD Disclosure · Company UpdateJul 9, 20248-KReg FD Disclosure · Company UpdateJun 3, 20248-KShareholder VoteMay 13, 202410-QFORM 10-QMay 9, 20248-KResults of OperationsMay 8, 2024DEFA14AFORM DEFA14AApr 29, 20248-KMaterial Agreement · Agreement TerminatedApr 10, 2024DEFA14AFORM DEFA14AApr 3, 2024DEF 14AFORM DEF 14AApr 3, 202410-KFORM 10-KApr 1, 20248-KRestatement · Results of OperationsMar 28, 20248-KReg FD Disclosure · Company UpdateMar 27, 20248-KReg FD DisclosureMar 5, 20248-KReg FD DisclosureMar 4, 20248-KBylaw AmendmentFeb 28, 2024SC 13GSC 13GFeb 14, 20248-K/ACompany UpdateFeb 5, 2024SC 13GSC 13GJan 29, 20248-KExecutive ChangeJan 23, 20248-KReg FD Disclosure · Company UpdateJan 8, 20248-KReg FD DisclosureDec 27, 2023424B5424B5Nov 22, 20238-KMaterial Agreement · Acquisition / DispositionNov 20, 202310-QFORM 10-QNov 7, 20238-KResults of OperationsNov 7, 2023425FORM 425Oct 30, 20238-KCompany UpdateOct 30, 20238-KExecutive ChangeOct 10, 2023S-4S-4Sep 29, 2023DEFA14AFORM DEFA14AAug 31, 20238-KCompany UpdateAug 31, 2023425425Aug 31, 20238-KMaterial Agreement · New Debt / ObligationAug 31, 202310-QFORM 10-QAug 14, 20238-KResults of OperationsAug 14, 20238-KExecutive ChangeAug 7, 202310-QFORM 10-QMay 15, 20238-KExecutive Change · Results of OperationsMay 15, 2023

Insider Activity

In the 90 days to Feb 9, 2026: 5 sold $1.2M.

DateInsiderActionSharesPriceValue
Feb 9, 2026Mcfarlane Neil F.President and CEOSell14,625$8.56$125K
Feb 3, 2026Schafer JoshuaCCOSell10,500$9.19$96K
Feb 3, 2026Sangiovanni Timothy J.SVP, Finance & Corp ControllerSell3,000$9.18$28K
Feb 2, 2026Mcfarlane Neil F.President and CEOSell91,000$9.38$854K
Jan 30, 2026Quartel Adrian WChief Medical OfficerSell4,533$8.83$40K
Jan 30, 2026Thompson RahsaanChief Legal & ComplianceSell4,080$8.83$36K
Jan 30, 2026Schafer JoshuaCCOSell3,375$8.83$30K
Jan 30, 2026Sangiovanni Timothy J.SVP, Finance & Corp ControllerSell1,750$8.82$15K
Oct 10, 2025Mcfarlane Neil F.President and CEOSell19,500$10.82$211K

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance